The Coming Revolution: Ozempic Goes Generic, Opening Doors for Billions Worldwide
The Next Big Leap: Indian Pharma's Race for the Semaglutide Jackpot
The Great Divide: Will a Lifesaving HIV Drug Reach Everyone, or Just a Fortunate Few?
India's Bold Move: Revoking Novartis's Vymada Patent for Public Health